Abstracts tagged "pain management and treatment"

Abstract Number: 2288 • 2015 ACR/ARHP Annual Meeting
Effectiveness of Dry Needling and Exercise in Dizziness Caused By Cervical Myofascial Pain Syndrome
Tugba Aydin¹, Bahar Dernek², Tulin Senturk³, Ayse Karan⁴ and Cihan Aksoy⁵, ¹Physiotherapy and Rehabilitation, Okmeydani Training and Research Hospital, Istanbul, Turkey, ²Physical Medicine and Rehabilitation, Istanbul Kanuni Sultan Suleyman Education and Research Hospital, Istanbul, Turkey, ³Department of Otolaryngology, Bagcilar Education and Research Hospital, Istanbul, Turkey, ⁴Department of Physical Medicine and Rehabilitation, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, ⁵Department of Physical Medicine and Rehabilitation, Istanbul Medical Faculty, Istanbul Universty, ISTANBUL, Turkey
Background/Purpose: The aim of this study is to compare the effectiveness of dry needling therapy combined with exercise treatment (dry needling+exercise) with exercise treatment alone…
Abstract Number: 1912 • 2012 ACR/ARHP Annual Meeting
Colchicine, As Assessed by Target Joint Pain Scores, Is Effective At 16 Hours in Patients with Acute Gout Flares
Suman Wason¹, Thomas Lauterio¹, Steve Crockett¹ and Matthew W. Davis², ¹Clinical Development, URL Pharma, Philadelphia, PA, ²Clinical Pharmacology, URL Pharma, Philadelphia, PA
Background/Purpose: The management of patients with gout remains suboptimal, leading to increasing frequency and severity of recurrent flares that eventually lead to joint destruction and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].